Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 78.20
+2.70 (3.58%)
Apr 14, 2026, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.26 billion as of April 14, 2026. Its market cap has decreased by -27.62% in one year.
Market Cap
1.26B
Enterprise Value
1.23B
Revenue
250.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
78.20
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has decreased from 1.35B to 1.26B, a decrease of -6.92%. That is a compound annual growth rate of -1.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 1.26B | -33.85% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 140.41B |
| Getinge AB | 52.28B |
| Sectra AB | 45.32B |
| Camurus AB | 30.74B |
| BioInvent International AB | 1.50B |
| Medivir AB | 1.39B |
| Genovis AB (publ.) | 1.31B |
| BICO Group AB | 1.28B |